John A. Ward

Array ( [id] => 4288107 [patent_doc_number] => 06211163 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-03 [patent_title] => 'Methods for delivering DNA to the bloodstream using recombinant adeno-associated virus vectors' [patent_app_type] => 1 [patent_app_number] => 9/309042 [patent_app_country] => US [patent_app_date] => 1999-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12779 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/211/06211163.pdf [firstpage_image] =>[orig_patent_app_number] => 309042 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 415278 [patent_doc_number] => 07279462 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-10-09 [patent_title] => 'Somatic transgene immunization and related methods' [patent_app_type] => utility [patent_app_number] => 09/300959 [patent_app_country] => US [patent_app_date] => 1999-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 89 [patent_no_of_words] => 34433 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/279/07279462.pdf [firstpage_image] =>[orig_patent_app_number] => 09300959 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1147334 [patent_doc_number] => 06774119 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-08-10 [patent_title] => 'HERPES SIMPLEX VIRUS TYPE 1 (HSV-1)-DERIVED VECTOR FOR SELECTIVELY INHIBITING MALIGNANT CELLS AND METHODS FOR ITS USE TO TREAT CANCERS AND TO EXPRESS DESIRED TRAITS IN MALIGNANT AND NON-MALIGNANT MAMMALIAN CELLS' [patent_app_type] => B1 [patent_app_number] => 09/299817 [patent_app_country] => US [patent_app_date] => 1999-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 22 [patent_no_of_words] => 8830 [patent_no_of_claims] => 102 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/774/06774119.pdf [firstpage_image] =>[orig_patent_app_number] => 09299817 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6876480 [patent_doc_number] => 20010006633 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-07-05 [patent_title] => 'ADENOVIRUS-CHEMOTHERAPEUTIC COMBINATION FOR TREATING CANCER' [patent_app_type] => new-utility [patent_app_number] => 09/294263 [patent_app_country] => US [patent_app_date] => 1999-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6732 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0006/20010006633.pdf [firstpage_image] =>[orig_patent_app_number] => 09294263 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1165597 [patent_doc_number] => 06759518 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-07-06 [patent_title] => 'Single-chain multiple antigen-binding molecule, its preparation and use' [patent_app_type] => B1 [patent_app_number] => 09/288719 [patent_app_country] => US [patent_app_date] => 1999-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 12059 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 179 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/759/06759518.pdf [firstpage_image] =>[orig_patent_app_number] => 09288719 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1433383 [patent_doc_number] => 06340673 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-22 [patent_title] => 'Method of treating tumorigenic disease' [patent_app_type] => B1 [patent_app_number] => 09/283471 [patent_app_country] => US [patent_app_date] => 1999-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 9 [patent_no_of_words] => 21538 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/340/06340673.pdf [firstpage_image] =>[orig_patent_app_number] => 09283471 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4352797 [patent_doc_number] => 06218180 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-17 [patent_title] => 'Gene therapy for the treatment of solid tumors using recombinant adeno-associated virus vectors' [patent_app_type] => 1 [patent_app_number] => 9/267748 [patent_app_country] => US [patent_app_date] => 1999-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 10 [patent_no_of_words] => 19954 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/218/06218180.pdf [firstpage_image] =>[orig_patent_app_number] => 267748 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1062708 [patent_doc_number] => 06849452 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-02-01 [patent_title] => 'Methods for activating natural killer (NK) cells and means for carrying out said methods' [patent_app_type] => utility [patent_app_number] => 09/260512 [patent_app_country] => US [patent_app_date] => 1999-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 25 [patent_no_of_words] => 16678 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/849/06849452.pdf [firstpage_image] =>[orig_patent_app_number] => 09260512 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7773699 [patent_doc_number] => 08119395 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2012-02-21 [patent_title] => 'Vaccines, immunotherapeutics and methods for using the same' [patent_app_type] => utility [patent_app_number] => 09/622452 [patent_app_country] => US [patent_app_date] => 1999-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 30597 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/119/08119395.pdf [firstpage_image] =>[orig_patent_app_number] => 09622452 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7640201 [patent_doc_number] => 06395714 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-28 [patent_title] => 'Expressing gp140 fragment of primary HIV-1 isolate' [patent_app_type] => B1 [patent_app_number] => 09/256194 [patent_app_country] => US [patent_app_date] => 1999-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 14 [patent_no_of_words] => 3891 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/395/06395714.pdf [firstpage_image] =>[orig_patent_app_number] => 09256194 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1534901 [patent_doc_number] => 06489306 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-12-03 [patent_title] => 'Method of intranasal gene transfer for protection against respiratory infection' [patent_app_type] => B2 [patent_app_number] => 09/259411 [patent_app_country] => US [patent_app_date] => 1999-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 14857 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/489/06489306.pdf [firstpage_image] =>[orig_patent_app_number] => 09259411 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 739965 [patent_doc_number] => 07029680 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-04-18 [patent_title] => 'Delivery of immunogenic molecules vis HBsAg particles' [patent_app_type] => utility [patent_app_number] => 09/241595 [patent_app_country] => US [patent_app_date] => 1999-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 19 [patent_no_of_words] => 4397 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/029/07029680.pdf [firstpage_image] =>[orig_patent_app_number] => 09241595 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1374791 [patent_doc_number] => 06558952 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-06 [patent_title] => 'Treatment for diabetes' [patent_app_type] => B1 [patent_app_number] => 09/241100 [patent_app_country] => US [patent_app_date] => 1999-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 16 [patent_no_of_words] => 11125 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/558/06558952.pdf [firstpage_image] =>[orig_patent_app_number] => 09241100 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1478523 [patent_doc_number] => 06451770 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-17 [patent_title] => 'Bovine polynucletide vaccine for the intradermal route' [patent_app_type] => B1 [patent_app_number] => 09/232469 [patent_app_country] => US [patent_app_date] => 1999-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4809 [patent_no_of_claims] => 80 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/451/06451770.pdf [firstpage_image] =>[orig_patent_app_number] => 09232469 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4296466 [patent_doc_number] => 06251384 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-26 [patent_title] => 'Metastasis models using green fluorescent protein (GFP) as a marker' [patent_app_type] => 1 [patent_app_number] => 9/226856 [patent_app_country] => US [patent_app_date] => 1999-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7363 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 118 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/251/06251384.pdf [firstpage_image] =>[orig_patent_app_number] => 226856 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1188783 [patent_doc_number] => 06734014 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-05-11 [patent_title] => 'Methods and compositions for transforming dendritic cells and activating T cells' [patent_app_type] => B1 [patent_app_number] => 09/117764 [patent_app_country] => US [patent_app_date] => 1999-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 12 [patent_no_of_words] => 18428 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/734/06734014.pdf [firstpage_image] =>[orig_patent_app_number] => 09117764 [rel_patent_id] =>[rel_patent_doc_number] =>)